Initial Statement of Beneficial Ownership

This filing reports the initial beneficial ownership of Feng Zhou, who is identified as the Co-CEO and Director of China SXT Pharmaceuticals, Inc. (SXTC). The filing indicates that Feng Zhou holds 4 Class B Ordinary Shares. These shares are held indirectly through Feng Zhou Management Limited, a British Virgin Islands company wholly owned by Feng Zhou. He has the power and dispositive control over these securities. The report details the ownership structure and the nature of indirect ownership as per the provided documentation.